Mycronic publ AB (MYCR) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Mycronic publ AB stock SEK 303, price SEK 279, upside +8.7%, quality 56 out of 100. Rating: fairly valued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range kr 57.30 – kr 359.00 · fair‑value band kr 206.88 – kr 420.43 · the kr 278.80 price screens below the kr 302.94 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Mycronic publ in your weekly email
Every Wednesday you see whether Mycronic publ is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Mycronic AB (publ) develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally.
Show moreShow less
It operates through four segments: Pattern Generators, PCB Assembly, High-Volume, and Global Technologies. The Pattern Generators segment develops, manufactures, and markets mask writers and metrology systems for display manufacturing and production of semiconductors.
The PCB Assembly segment develops, manufactures, and markets flexible PCB assembly solutions, including jet printing, stencil printing, 3D inspection, component placement, and automated storage solutions.
The High-Volume segment develops, manufactures, and markets automated system for dispensing and conformal coating for high-volume electronics production. The Global Technologies segment offers die bonding, PCB test, photonic interconnects, magnetic test, and applied plasma.
The company sells its products through agents and distributors. It serves aerospace, defense, medical, and industrial electronics sectors. The company was formerly known as Micronic Mydata AB (publ) and changed its name to Mycronic AB (publ) in June 2014.
Mycronic AB (publ) was incorporated in 1989 and is headquartered in Täby, Sweden.
Stock analysis
Mycronic publ AB (MYCR) currently trades at kr 278.80, while our model-based Fair Value estimate is kr 302.94, so the stock looks roughly fairly valued today (gap 8.0%).
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of kr 252.17 per share, and 2 of the 25 models we run sit above the kr 278.80 price.
Bear case: the Dividend Discount group reads lowest at kr 70.28, and 23 of the 25 models stay below the price. Data coverage for this calculation is high.
Scenario range: kr 206.88 (bear) to kr 420.43 (bull), the price of kr 278.80 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 56/100 (solid quality), in the Industrials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Mycronic publ AB reported revenue of 7.9B SEK in FY2025 versus 4.6B SEK in FY2021, a compound +14.4%/yr. Reported net income was 1.6B SEK in FY2025, compounding +17.2%/yr from FY2021.
Key figures
Market cap 53.9B SEK (≈ $5.4B) Mid · P/E ratio 27.4 · P/S ratio 5.80 · EPS (TTM) kr 10.19 · Dividend yield 1.2% · Net margin 21.4% · Return on equity 25.8% · Return on assets (EBIT) 16.2% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 83 out of 100 (low confidence).
What moves the price
The share trades about 22% below its 52-week high and 49% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −46% fair-value upside, at 9%, MYCR screens cheaper than that median.
Fair Value models
Bearkr 206.88Fair Value kr 302.94Bullkr 420.43
Price kr 278.80 · Upside +8.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (kr 5.93 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+12.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.4%
Start year 2020 (pandemic). Over 10 years: +15.9% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.2%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
0.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−1.2%
Dividend (yield on the price)1.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−1.2% vs 5.9%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.23% → 25%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+19.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+8.8%
Yearly sales growth analysts expect, extended to five years.
After inflation (Sweden: IMF forecast 2.0% a year to 2030, 2.9% from 2016 to 2025) that is about +16.8% a year for the price and +6.7% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (53 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
AI conclusion: Strong reported margins and cash flow provide a solid base, yet limited public data and primary exposure to electronics and semiconductor cycles limit durable quality assessment.
Main risk: Continued reliance on cyclical consumer electronics and semiconductor markets would hit demand stability and revenue predictability.
Mycronic recently secured a turnkey order for a complete advanced circuit board manufacturing solution from a Nordic defense industry supplier. This development points to growing traction in the defense sector alongside its established position in electronics production equipment. Will the business gain more lasting stability from such defense and automation partnerships or stay primarily exposed to the cycles of consumer electronics and semiconductor markets?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Industrial Machinery · 814 stocks
Beats the industry median on 9/15 measures
Overall it ranks above its industry peers.
Valuation
Quality Score56 · Above median
Fair Value upside+8.7% · Above median
Profitability
Return on equity (12 months)25.8% · Top 25%
Return on assets14.3% · Top 25%
Net margin (12 months)21.4% · Top 25%
Operating margin (12 months)25.9% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)37.9% · Top 25%
Dividend yield (12 months)1.2% · Below median
Balance sheet
Debt / equity0.00× · Lowest 25%
Valuation Multiplesvs Specialty Industrial Machinery median · lower = cheaper
P/E (12 months)27.4× · Pricier than median
P/B7.58× · Priciest 25%
P/S (12 months)5.80× · Priciest 25%
Price / free cash flow (fiscal year)41.0× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Mycronic publ AB Fair Value". https://www.fairvalue-calculator.com/stock/MYCR
Frequently asked questions
Is Mycronic publ AB (MYCR) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of kr 302.94 versus a price of kr 278.80, about +9% upside (fairly valued).
What is the fair value of MYCR?
Our model-based fair value for Mycronic publ AB is kr 302.94 (as of Nov 6, 2026), built from audited fundamentals. The current price: kr 278.80.
What is the quality score of MYCR?
Mycronic publ AB has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Mycronic publ AB (MYCR)?
Our model-based price target is the fair value of kr 302.94 (as of Nov 6, 2026) from 25 valuation models. Cautious scenario kr 206.88, optimistic scenario kr 420.43. It is a calculation from audited fundamentals, not an analyst target.
What is the Mycronic publ AB stock forecast for 2026?
Our models put fair value at kr 302.94, about +9% upside versus a price of kr 278.80 (fairly valued). Cautious scenario kr 206.88, optimistic scenario kr 420.43. The calculation is refreshed regularly with new filings.
What is the revenue of Mycronic publ AB (MYCR)?
Mycronic publ AB reported trailing-twelve-month revenue of about 9.3B SEK (latest available figure, as of Nov 6, 2026).
Does Mycronic publ AB pay a dividend?
Mycronic publ AB currently shows a dividend yield of 1.17% relative to its recent price (as of Nov 6, 2026).
How much is the dividend of Mycronic publ AB (MYCR) and when is the ex-dividend date?
Mycronic publ AB pays a dividend of kr 3.25 per share a year, a dividend yield of 1.2%. The last ex-dividend date was May 7, 2026. A dividend has been paid every year since at least 2014. The payout ratio is 31.9% of earnings. Free cash flow covers the dividend 2.07 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Mycronic publ AB (MYCR)?
For today's price to be fair in a discounted-cash-flow model, Mycronic publ AB would have to grow free cash flow by +19.1 % per year for five years (discount rate 8.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +15.4 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of MYCR use?
Our models discount Mycronic publ AB at 8.6 %: a base by market capitalisation (mid), damped by beta 0.63, country premium for Sweden. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Mycronic publ AB that is +19.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (8.6 %) and the same formula as our fair value.
How much growth has Mycronic publ AB (MYCR) delivered so far?
Over the past 5 years revenue at Mycronic publ AB grew +15.4 % a year. The price currently implies free-cash-flow growth of +19.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Mycronic publ AB (MYCR) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into Mycronic publ AB (+19.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Mycronic publ AB (MYCR)?
The free-cash-flow yield on the price is 2.42 %: that much free cash flow Mycronic publ AB produces per unit of market value. When it exceeds the discount rate of our models (8.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Mycronic publ AB (MYCR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Mycronic publ AB it is kr 302.94 per share (as of Nov 6, 2026), against a price of kr 278.80. It is the blended result of 25 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Mycronic publ AB stock overvalued or undervalued in 2026?
As of Nov 6, 2026, MYCR trades below its calculated fair value: price kr 278.80, fair value kr 302.94, a gap of about +9% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MYCR?
No. The price is what the market pays today (kr 278.80); the fair value is what the company's own numbers justify (kr 302.94). For Mycronic publ AB the two are kr 24.14 per share apart. That gap is exactly why we show both numbers side by side.
How much is Mycronic publ AB worth?
The market values Mycronic publ AB at about 53.9B SEK (market capitalisation, as of Nov 6, 2026). Per share that is kr 278.80; our models calculate a fair value of kr 302.94 per share.
What do the bullish and bearish scenarios say about MYCR?
Our models span a range for Mycronic publ AB: cautious scenario kr 206.88, base kr 302.94, optimistic kr 420.43 per share (as of Nov 6, 2026, price kr 278.80). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MYCR?
Mycronic publ AB trades at a price-to-earnings ratio of 27.4 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 302.94 is built from several models across several years. Other multiples: PEG 0.4, P/B 7.6, P/S 5.8, EV/EBITDA 17.4.
What is the PEG ratio of MYCR?
The PEG ratio of Mycronic publ AB is 0.42 (P/E divided by earnings growth, as of Nov 6, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Mycronic publ AB (MYCR)?
Balance-sheet figures for Mycronic publ AB (as of Nov 6, 2026): return on equity 25.8%, debt of 0.00 per unit of equity. They feed the Quality Score of 56/100, which measures business quality independently of the share price.
How far is MYCR from its 52-week high?
Mycronic publ AB trades at kr 278.80, about 22% below its 52-week high of kr 359.00 and 49% above the low of kr 186.82 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of kr 302.94 is for.
Which stocks are comparable to Mycronic publ AB?
From the same area (Industrials) we also value SIE, GE Vernova Inc, Eaton Corporation, Parker-Hannifin Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Mycronic publ AB stock attractive at the current price?
The data as of Nov 6, 2026: price kr 278.80, calculated fair value kr 302.94 (+9%), Quality Score 56/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MYCR calculated?
We run Mycronic publ AB through 25 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of kr 302.94 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Mycronic publ AB currently trades 8% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Mycronic publ AB (MYCR)?
The closing price on Nov 6, 2026 was kr 278.80. Our model-based fair value is kr 302.94, about +9% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Mycronic publ AB right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (kr 206.88 to kr 420.43) leaves room in how you read the outcome.
Where does the earnings growth of Mycronic publ AB (MYCR) come from?
Earnings per share at Mycronic publ AB grew +11.1 % a year from 2014 to 2025. Broken into its drivers: revenue per share +12.0 %, EBIT margin −0.8 %, tax rate −0.3 %, residual (interest, one-offs) +0.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Mycronic publ AB
How large is the market capitalisation of Mycronic publ AB (MYCR)?
The market capitalisation of Mycronic publ AB is 53.9B SEK (≈ $5.4B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Mycronic publ AB (MYCR)?
The price-to-sales ratio of Mycronic publ AB is 5.80 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Mycronic publ AB (MYCR)?
Earnings per share at Mycronic publ AB are kr 10.19 (price ÷ EPS = P/E 27.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Mycronic publ AB (MYCR)?
The dividend yield of Mycronic publ AB is 1.2% (payout 31.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Mycronic publ AB (MYCR)?
The net margin of Mycronic publ AB is 21.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Mycronic publ AB (MYCR)?
The return on equity (ROE) of Mycronic publ AB is 25.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Mycronic publ AB (MYCR)?
On an EBIT basis the return on assets of Mycronic publ AB is 16.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Mycronic publ AB (MYCR)?
The operating margin of Mycronic publ AB is 25.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Mycronic publ AB (MYCR)?
Revenue at Mycronic publ AB is growing +37.9% versus a year earlier (3y avg +15.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Mycronic publ AB (MYCR)?
Earnings per share at Mycronic publ AB are growing +117% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Mycronic publ AB (MYCR) hold?
Mycronic publ AB holds more cash than debt, 2.0B SEK net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Mycronic publ AB in the live analysis
One click puts Mycronic publ AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 6, 2026